Integrating real-world data to assess cardiac ablation device outcomes in a multicenter study using the OMOP common data model for regulatory decisions: implementation and evaluation.

IF 2.5 Q2 HEALTH CARE SCIENCES & SERVICES
Yue Yu, Guoqian Jiang, Eric Brandt, Tom Forsyth, Sanket S Dhruva, Shumin Zhang, Jiajing Chen, Peter A Noseworthy, Amit A Doshi, Kimberly Collison-Farr, Dure Kim, Joseph S Ross, Paul M Coplan, Joseph P Drozda
{"title":"Integrating real-world data to assess cardiac ablation device outcomes in a multicenter study using the OMOP common data model for regulatory decisions: implementation and evaluation.","authors":"Yue Yu,&nbsp;Guoqian Jiang,&nbsp;Eric Brandt,&nbsp;Tom Forsyth,&nbsp;Sanket S Dhruva,&nbsp;Shumin Zhang,&nbsp;Jiajing Chen,&nbsp;Peter A Noseworthy,&nbsp;Amit A Doshi,&nbsp;Kimberly Collison-Farr,&nbsp;Dure Kim,&nbsp;Joseph S Ross,&nbsp;Paul M Coplan,&nbsp;Joseph P Drozda","doi":"10.1093/jamiaopen/ooac108","DOIUrl":null,"url":null,"abstract":"<p><p>The objective of this study is to describe application of the Observational Medical Outcomes Partnership (OMOP) common data model (CDM) to support medical device real-world evaluation in a National Evaluation System for health Technology Coordinating Center (NESTcc) Test-Case involving 2 healthcare systems, Mercy Health and Mayo Clinic. CDM implementation was coordinated across 2 healthcare systems with multiple hospitals to aggregate both medical device data from supply chain databases and patient outcomes and covariates from electronic health record data. Several data quality assurance (QA) analyses were implemented on the OMOP CDM to validate the data extraction, transformation, and load (ETL) process. OMOP CDM-based data of relevant patient encounters were successfully established to support studies for FDA regulatory submissions. QA analyses verified that the data transformation was robust between data sources and OMOP CDM. Our efforts provided useful insights in real-world data integration using OMOP CDM for medical device evaluation coordinated across multiple healthcare systems.</p>","PeriodicalId":36278,"journal":{"name":"JAMIA Open","volume":"6 1","pages":"ooac108"},"PeriodicalIF":2.5000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/28/b6/ooac108.PMC9831049.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAMIA Open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jamiaopen/ooac108","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 1

Abstract

The objective of this study is to describe application of the Observational Medical Outcomes Partnership (OMOP) common data model (CDM) to support medical device real-world evaluation in a National Evaluation System for health Technology Coordinating Center (NESTcc) Test-Case involving 2 healthcare systems, Mercy Health and Mayo Clinic. CDM implementation was coordinated across 2 healthcare systems with multiple hospitals to aggregate both medical device data from supply chain databases and patient outcomes and covariates from electronic health record data. Several data quality assurance (QA) analyses were implemented on the OMOP CDM to validate the data extraction, transformation, and load (ETL) process. OMOP CDM-based data of relevant patient encounters were successfully established to support studies for FDA regulatory submissions. QA analyses verified that the data transformation was robust between data sources and OMOP CDM. Our efforts provided useful insights in real-world data integration using OMOP CDM for medical device evaluation coordinated across multiple healthcare systems.

Abstract Image

Abstract Image

Abstract Image

在一项多中心研究中,使用OMOP通用数据模型评估心脏消融装置的疗效:实施和评估。
本研究的目的是描述观察性医疗结果伙伴关系(OMOP)公共数据模型(CDM)在国家卫生技术协调中心评估系统(NESTcc)测试案例中的应用,以支持医疗器械的真实世界评估,涉及两个医疗保健系统,Mercy health和Mayo Clinic。CDM的实施在两个医疗保健系统和多家医院之间进行了协调,以汇总来自供应链数据库的医疗设备数据以及来自电子健康记录数据的患者结果和协变量。在OMOP CDM上实现了几个数据质量保证(QA)分析,以验证数据提取、转换和加载(ETL)过程。基于OMOP cdm的相关患者遭遇数据已成功建立,以支持FDA监管提交的研究。QA分析验证了数据源与OMOP CDM之间数据转换的鲁棒性。我们的工作为使用OMOP CDM进行跨多个医疗保健系统协调的医疗设备评估提供了实际数据集成方面的有用见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
JAMIA Open
JAMIA Open Medicine-Health Informatics
CiteScore
4.10
自引率
4.80%
发文量
102
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信